4.5 Article

Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-β

Journal

JOURNAL OF CELL SCIENCE
Volume 122, Issue 11, Pages 1917-1926

Publisher

COMPANY BIOLOGISTS LTD
DOI: 10.1242/jcs.042226

Keywords

HtrA2 (Omi); Heat-shock protein; Oligomeric amyloid-beta protein; Protein interaction; Mutual detoxification; Disaggregation

Categories

Funding

  1. Korean Ministry of Education and Human Resources Development through the Center for Healthcare Technology Development

Ask authors/readers for more resources

The cellular generation of toxic metabolites and subsequent detoxification failure can cause the uncontrolled accumulation of these metabolites in cells, leading to cellular dysfunction. Amyloid-beta protein (A beta), a normal metabolite of neurons, tends to form toxic oligomeric structures that cause neurodegeneration. It is unclear how healthy neurons control the levels of intracellular oligomeric A beta in order to avoid neurodegeneration. Using immunochemical and biochemical studies, we show that the A beta-binding serine protease Omi is a stress-relieving heat-shock protein that protects neurons against neurotoxic oligomeric A beta. Through its PDZ domain, Omi binds preferentially to neurotoxic oligomeric forms of A beta rather than non-toxic monomeric forms to detoxify oligomeric A beta by disaggregation. This specific interaction leads not only to mutual detoxification of the pro-apoptotic activity of Omi and A beta-induced neurotoxicity, but also to a reduction of neurotoxic-A beta accumulation. The neuroprotective role of Omi is further supported by its upregulation during normal neurogenesis and neuronal maturation in mice, which could be in response to the increase in the generation of oligomeric A beta during these processes. These findings provide novel and important insights into the detoxification pathway of intraneuronal oligomeric A beta in mammals and the protective roles of Omi in neurodegeneration, suggesting a novel therapeutic target in neurodegenerative diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Identification and Characterization of Plasmin-Independent Thrombolytic Enzymes

Md Mehedi Hassan, Shirina Sharmin, Hyeon-Jin Kim, Seong-Tshool Hong

Summary: HtrA1 and HtrA2/Omi proteins have been identified as plasmin-independent and highly specific thrombolytics that can dissolve intravascular thrombi specifically without causing bleeding risk. This study provides HtrA1 and HtrA2/Omi as ideal therapeutic candidates for various thrombotic diseases without hemorrhagic complications.

CIRCULATION RESEARCH (2021)

Correction Cell Biology

WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer (vol 11, 1001, 2020)

Ayse Ertay, Huiquan Liu, Dian Liu, Ping Peng, Charlotte Hill, Hua Xiong, David Hancock, Xianglin Yuan, Marcin R. Przewloka, Mark Coldwell, Michael Howell, Paul Skipp, Rob M. Ewing, Julian Downward, Yihua Wang

CELL DEATH & DISEASE (2021)

Article Multidisciplinary Sciences

Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers

Tereza Vaclova, Ursula Grazini, Lewis Ward, Daniel O'Neill, Aleksandra Markovets, Xiangning Huang, Juliann Chmielecki, Ryan Hartmaier, Kenneth S. Thress, Paul D. Smith, J. Carl Barrett, Julian Downward, Elza C. de Bruin

Summary: T790M subclonality is associated with poorer response to osimertinib and shorter progression-free survival, likely due to co-occurring PIK3CA alterations which can be targeted by PI3K pathway inhibitors.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Quantitative Proteomic Analysis in Alveolar Type II Cells Reveals the Different Capacities of RAS and TGF-β to Induce Epithelial-Mesenchymal Transition

Yilu Zhou, Charlotte Hill, Liudi Yao, Juanjuan Li, David Hancock, Julian Downward, Mark G. Jones, Donna E. Davies, Rob M. Ewing, Paul Skipp, Yihua Wang

Summary: Alveolar type II (ATII) epithelial cells function as stem cells and are crucial for alveolar renewal, repair, and cancer. Research has shown that RAS activation induces epithelial-mesenchymal transition (EMT), while activation of the TGF-beta signaling pathway alone only induces partial EMT.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Genetics & Heredity

Inherited duplications of PPP2R3B predispose to nevi and melanoma via a C21orf91-driven proliferative phenotype

Satyamaanasa Polubothu, Davide Zecchin, Lara Al-Olabi, Daniel A. Lionarons, Mark Harland, Stuart Horswell, Anna C. Thomas, Lilian Hunt, Nathan Wlodarchak, Paula Aguilera, Sarah Brand, Dale Bryant, Cristina Carrera, Hui Chen, Greg Elgar, Catherine A. Harwood, Michael Howell, Lionel Larue, Sam Loughlin, Jeff MacDonald, Josep Malvehy, Sara Martin Barberan, Vanessa Martins da Silva, Miriam Molina, Deborah Morrogh, Dale Moulding, Jeremie Nsengimana, Alan Pittman, Juan-Anton Puig-Butille, Kiran Parmar, Neil J. Sebire, Stephen Scherer, Paulina Stadnik, Philip Stanier, Gemma Tell, Regula Waelchli, Mehdi Zarrei, Susana Puig, Veronique Bataille, Yongna Xing, Eugene Healy, Gudrun E. Moore, Wei-Li Di, Julia Newton-Bishop, Julian Downward, Veronica A. Kinsler

Summary: This study identified a previously unreported genetic susceptibility to melanoma and melanocytic nevi, familial duplications of gene PPP2R3B. Duplications of this gene increase the expression of PR70 in human nevus and melanoma tissue, affecting survival through a nonimmunological mechanism. Overexpression of PPP2R3B induces pigment cell switching toward proliferation and away from migration, driven by C21orf91 independent of the known MITF-controlled switch. This work confirms the power of a rare disease approach and identifies C21orf91 as a potentially targetable hub in controlling phenotype switching.

GENETICS IN MEDICINE (2021)

Article Biochemistry & Molecular Biology

Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosis

Liudi Yao, Yilu Zhou, Juanjuan Li, Leanne Wickens, Franco Conforti, Anna Rattu, Fathima Maneesha Ibrahim, Aiman Alzetani, Ben G. Marshall, Sophie Fletcher, David Hancock, Tim Wallis, Julian Downward, Rob M. Ewing, Luca Richeldi, Paul Skipp, Donna E. Davies, Mark G. Jones, Yihua Wang

Summary: The study identified aberrant bidirectional epithelial-mesenchymal crosstalk in IPF, forming a chronic feedback loop that maintains profibrotic signals.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Cell Biology

Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer

Stelios Chrysostomou, Rajat Roy, Filippo Prischi, Lucksamon Thamlikitkul, Kathryn L. Chapman, Uwais Mufti, Robert Peach, Laifeng Ding, David Hancock, Christopher Moore, Miriam Molina-Arcas, Francesco Mauri, David J. Pinato, Joel M. Abrahams, Silvia Ottaviani, Leandro Castellano, Georgios Giamas, Jennifer Pascoe, Devmini Moonamale, Sarah Pirrie, Claire Gaunt, Lucinda Billingham, Neil M. Steven, Michael Cullen, David Hrouda, Mathias Winkler, John Post, Philip Cohen, Seth J. Salpeter, Vered Bar, Adi Zundelevich, Shay Golan, Dan Leibovici, Romain Lara, David R. Klug, Sophia N. Yaliraki, Mauricio Barahona, Yulan Wang, Julian Downward, J. Mark Skehel, Maruf M. U. Ali, Michael J. Seckl, Olivier E. Pardo

Summary: The study identified RSK4 as a driver of drug resistance and metastasis in lung and bladder cancer cells, and silencing this kinase increased sensitivity to chemotherapy and reduced metastasis. Drug screening revealed fluoroquinolone antibiotics as potent RSK4 inhibitors, with trovafloxacin replicating effects of RSK4 silencing. Further structural analysis provided insights into how trovafloxacin blocks RSK4 kinase activation. Additionally, patients receiving chemotherapy and prophylactic levofloxacin showed significantly prolonged overall survival, suggesting RSK4 inhibition as a potential therapeutic strategy for lung and bladder cancer.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition

Tereza Vaclova, Atanu Chakraborty, James Sherwood, Sarah Ross, Danielle Carroll, J. Carl Barrett, Julian Downward, Elza C. de Bruin

Summary: The study investigates the co-occurrence of additional KRAS mutations with KRAS G12C in non-small cell lung cancer (NSCLC) tumors and its impact on cellular response to G12C-specific inhibitors. The results show that KRAS c.35G>T mutation most frequently co-occurred with KRAS G12C and led to cellular resistance to G12C inhibitors. Therefore, comprehensive genotyping of KRAS tumors is necessary for optimal patient selection for treatment with a KRAS G12C inhibitor.

SCIENTIFIC REPORTS (2022)

Article Microbiology

Host Factors Affect the Gut Microbiome More Significantly than Diet Shift

Enkhchimeg Lkhagva, Hea-Jong Chung, Ji-Seon Ahn, Seong-Tshool Hong

Summary: This study compared the impact of transitioning from a meatatarian diet to a vegetarian diet and engaging in physical exercise on the composition of the gut microbiome. The results showed that physical exercise had a more significant effect on the microbiome composition than diet transition, with differences in the patterns of change and diversity.

MICROORGANISMS (2021)

Article Microbiology

Comparative Analysis of Original and Replaced Gut Microbiomes within Same Individuals Identified the Intestinal Microbes Associated with Weight Gaining

Chongkai Zhai, Ji-Seon Ahn, Md Minarul Islam, Enkhchimeg Lkhagva, Hea-Jong Chung, Seong-Tshool Hong

Summary: This study analyzes the effects of gut microbiome on host phenotype by replacing the original gut microbiome with a new one within the same individual. The results show that different gut microbiomes have different effects on weight gain, and weight gain is negatively correlated with the Firmicutes/Bacteroidetes ratio.

MICROORGANISMS (2022)

Editorial Material Medicine, General & Internal

The Potency of a KRAS Silent Variant

Miriam Molina-Arcas, Julian Downward

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Multidisciplinary Sciences

RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma

Philip East, Gavin P. Kelly, Dhruva Biswas, Michaela Marani, David C. Hancock, Todd Creasy, Kris Sachsenmeier, Charles Swanton, Julian Downward, Sophie de Carne Trecesson

Summary: The study found that 84% of patients with lung adenocarcinoma have oncogenic activation of the RAS signaling pathway, with a high proportion of activation even in KRAS wild-type tumors; patient groups with high RAS activity show adverse clinical outcomes and reduced response to chemotherapy. Stratifying patients based on oncogenic RAS transcriptional activity may ultimately assist in clinical decision-making.

NATURE COMMUNICATIONS (2022)

Article Biochemical Research Methods

Micro-CT acquisition and image processing to track and characterize pulmonary nodules in mice

May Zaw Thin, Christopher Moore, Thomas Snoeks, Tammy Kalber, Julian Downward, Axel Behrens

Summary: In this paper, a method of lung nodule image acquisition and analysis using a micro-computed tomography scanner is introduced for translational research in lung cancer that closely mimics clinical environments. The method has the advantages of low radiation dose, high resolution, and high-throughput imaging, and utilizes specific image analysis tools for identifying different types of lung tumors.

NATURE PROTOCOLS (2023)

Article Biochemistry & Molecular Biology

Identification of the Intestinal Microbes Associated with Locomotion

Ji-Seon Ahn, Yu-Jin Choi, Han-Byeol Kim, Hea-Jong Chung, Seong-Tshool Hong

Summary: This study demonstrates that the gut microbiome can contribute differently to locomotion and explains the mixed results in previous research on the association between the gut microbiome and locomotion.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

The Pathological Role of miRNAs in Endometriosis

Mst Ismat Ara Begum, Lin Chuan, Seong-Tshool Hong, Hee-Suk Chae

Summary: Association studies have shown that miRNA expression is significantly altered in relation to diseases, including endometriosis (EMS), particularly within inflammatory pathways. This article reviews the advancements made in understanding the pathological role of miRNA in EMS and its association with EMS-associated infertility, highlighting the potential for developing miRNA-based therapeutics and diagnostic markers.

BIOMEDICINES (2023)

No Data Available